What is HCA Healthcare's current analyst consensus after the downgrades?

Despite multiple price target cuts, the analyst consensus remains Overweight/Outperform with a mean target of approximately $519–$551, implying significant upside from the current price of $442.51.

Which other analysts cut HCA Healthcare targets at the same time?

RBC (to $534), Oppenheimer (to $520), Wells Fargo (to $436), and Jefferies (to $525) all cut targets alongside KeyBanc, with Jefferies citing weather-related volume impacts.

Does the HCA earnings miss affect other hospital stocks?

Yes — hospital peers like Tenet Healthcare Corporation face sympathy risk as they share the same utilization-trend fundamentals. Sector-wide healthcare ETFs may also see mild bearish pressure.

Is HCA Healthcare stock a buy after the price target cuts?

Analysts maintain Buy/Overweight ratings with 17–24% upside to consensus targets, but short-term momentum is negative. Traders should monitor volume confirmation and earnings guidance before establishing long positions.

快速連結

KeyBanc 大幅下調 HCA Healthcare 目標價至 $510，因疲弱季度導致分析師普遍下調評級

發佈時間: 2026-04-27 14:24:09 UTC

查看 HCA 頁碼

數據快照

Price

$441.94

24h Low

$434.38

24h High

$445.35

24h Change

+2.17%

24h Change (%)

+2.04%

KeyBanc New PT

$510 (from $550)

HCA Current Price

$442.51

Analyst Consensus Mean PT

$519–$551

重點摘要

•KeyBanc cut HCA's price target from $550 to $510; at least 5 major firms revised targets lower simultaneously, signaling broad earnings disappointment.
•HCA's current live price of $442.51 sits well below the analyst consensus target of ~$519–$551, implying 17–24% upside but with negative short-term momentum.
•Weather-related volume headwinds (cited by Jefferies) and post-COVID utilization normalization are the key fundamental drivers of the weak quarter.
•Sector peers including Tenet Healthcare and UnitedHealth Group face sympathy risk; monitor hospital utilization data as a leading indicator.
•Despite the downgrades, all cutting analysts maintained Buy/Overweight ratings — this is a valuation recalibration, not a thesis abandonment.

HCA Healthcare, Inc. (NYSE: HCA) — 美國最大的私人醫院運營商，擁有 190 家醫院和 121 家手術中心 — 在季度表現失利後，引發了一波分析師對其目標價的下調。根據 Futunn 和 MarketScreener 的報導，KeyBanc Capital Markets 將其目標價從 $550 下調至 $510（約下降 7.3%），同時維持增持評級。這一行動並非孤

事件分析

HCA Healthcare, Inc. (NYSE: HCA) — 美國最大的私人醫院運營商，擁有 190 家醫院和 121 家手術中心 — 在季度表現失利後，引發了一波分析師對其目標價的下調。根據 Futunn 和 MarketScreener 的報導，KeyBanc Capital Markets 將其目標價從 $550 下調至 $510（約下降 7.3%），同時維持增持評級。這一行動並非孤立：RBC 從 $593 下調至 $534，Oppenheimer 從 $540 下調至 $520，Wells Fargo 從 $481 下調至 $436，以及 Jefferies 從 $590 下調至 $525 —— 後者指出由於天氣相關的交易量影響。

這一波下調的特別之處在於其廣泛性和同步性。多家大型及中型投資銀行同時調整目標價，這不僅顯示出一次性失利的現象，還指向了醫院使用情況的結構性疲軟。Jefferies 對天氣影響的特別提及表明 2026 年第一季度的交易量受到外部因素的壓制，但修正幅度的規模意味著潛在需求正常化也在發揮作用，因為 COVID-19 以後的醫療追趕交易量正在減少。這是一種盈利失利帶來的收入衝擊模式，值得對整個醫院行業進行監控。

儘管目標價被下調，市場共識仍然看好。根據 ValueInvesting.io 和 TickerNerd 的數據，分析師的平均目標價約在 $519–$551 之間，意味著從 HCA 當前報價 $442.51 有 17–24% 的上漲空間。來自 25–45 位分析師的增持/優於市場共識保持不變，這表明這是一個估值重置，而非論點破裂。分析師目標價與目前價格之間的差距意味著 HCA 可能吸引逢低買入者，但由於修正的節奏，短期內動能仍然為負。交易者在進入頭寸前可以通過 CoinUnited.io 查看未平倉合約量和資金費率以確認方向。

行業 contagion 是次要的關注點。Tenet Healthcare Corporation 和 UnitedHealth Group Incorporated 受到情緒影響，因為醫院使用數據是共享的基本面。考慮到醫療行業的特定動態，廣泛的 S&P 500 指數和 NASDAQ 100 指數曝露有限，但大型醫療公司持續回調可能會使防禦性投資組合產生輕微的避險情緒。持有醫療行業曝露的交易者應查看跨市場交易行業的完整指南以獲取行業整體盈利趨勢如何影響佈局策略的背景資訊。

在 CoinUnited.io 交易 HCA Healthcare, Inc.

以高達 800 倍槓桿交易 HCA | 免費創建帳戶

常見問題

KeyBanc reduced its price target from $550 to $510 following a weak quarterly performance by HCA Healthcare, reflecting disappointing hospital utilization volumes. The firm maintained its Overweight rating, signaling the cut is a recalibration rather than a bearish stance shift.